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Purpose
Cardiovascular disease (CVD), a major cause of death
and substantial healthcare costs, is also largely preventa-
ble. The purpose of this study is to determine the cost-
effectiveness of a naturopathic approach to the primary
prevention of cardiovascular disease.
Methods
This study is an economic evaluation alongside a prag-
matic, multi-worksite, randomized trial comparing
enhanced usual care (EUC; usual care plus biometric
screening) to the addition of a naturopathic approach to
CVD prevention (NC+EUC; an individualized package
of lifestyle counseling and nutritional medicine). Bio-
metric and self-report outcomes were collected at 0, 6,
and 12 months. Cost-effectiveness is determined from
the societal and employer perspectives for participants
who consented (before randomization) to make available
their electronic employer sick leave and medical claims
data.
Results
Of the 246 employees who consented to the trial, two-
thirds also gave consent to make available their claims
a n ds i c kl e a v ed a t a :7 7( 6 3 . 1 %o f1 2 2 )r a n d o m i z e dt o
EUC and 79 (63.7% of 124) randomized to NC+EUC.
There were no statistically significant differences
between those who did and did not give this consent
across baseline characteristics, outcomes, or tendency to
miss study visits. After one year NC+EUC resulted in a
net decrease of 3.3 (CI: 1.7 -4.8) percentage points in
10-year CVD event risk (NNT=30) and 0.9 (CI: 0.2 –
1.6) points in CVD mortality risk (NNT=111). These
risk reductions came with an average net savings of
$1138 in societal costs and $1187 in employer costs.
There was no change in quality-adjusted life-years
across the study year.
Conclusion
In this multi-worksite-based study, a naturopathic
approach to the primary prevention of CVD provided
significant reductions in CVD risk over usual care plus
biometric screening. These risk reductions are achieved
with cost savings to society and employers. Further
research into naturopathic approaches to CVD risk
reduction is justified.
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